Tags

Type your tag names separated by a space and hit enter

Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia.
Infect Dis (Lond) 2018; 50(2):133-139ID

Abstract

BACKGROUND

We aimed to evaluate the prevalence of sexually transmitted infections (STI, including Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) among high-risk heterosexual male patients and to clarify their potency to cause complaints and inflammation.

METHODS

The study group included 825 men (18.0-49.5 y) consulting andrologist at Tartu University Hospital (Estonia) due to subjectively perceived risk of STI. Patients completed STI risk behaviour questionnaire. First voided urine was analysed for white blood cells and STIs.

RESULTS

In total 193 (23.4%) patients were positive for one or multiple STI. The prevalence of C. trachomatis, M. genitalium, N. gonorrhoeae, T. vaginalis and combined STI was 14.3%, 4.4%, 2.7%, 0.7% and 1.3%, respectively. N. gonorrhoeae had the highest potency to generate inflammatory reaction in first voided urine (100%) followed by C. trachomatis (72.0%), M. genitalium (63.9%) and T. vaginalis (33.3%). N. gonorrhoeae and T. vaginalis caused the highest mean number of complaints while half of T. vaginalis cases and nearly fifth of M. genitalium and C. trachomatis cases were asymptomatic.

CONCLUSIONS

C. trachomatis has the highest prevalence among Estonian high-risk men but M. genitalium holds an important second place. Prevalence of combined STIs is low. N. gonorrhoeae has the highest potency to generate urethral inflammation followed by C. trachomatis and M. genitalium. The highest number of complaints is also associated with N. gonorrhoeae while half of T. vaginalis cases and nearly a fifth of M. genitalium and C. trachomatis cases are asymptomatic.

Authors+Show Affiliations

a Tartu University Hospital, Centre of Andrology , Tartu , Estonia. b Faculty of Medicine , University of Tartu , Tartu , Estonia.c Department of Microbiology, Faculty of Medicine , University of Tartu, Institute of Biomedicine and Translational Medicine , Tartu , Estonia. d Competence Centre on Health Technologies , Tartu , Estonia.a Tartu University Hospital, Centre of Andrology , Tartu , Estonia. e Department of Surgery, Faculty of Medicine , University of Tartu, Institute of Clinical Medicine , Tartu , Estonia.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28868962

Citation

Tjagur, Stanislav, et al. "Prevalence of Mycoplasma Genitalium and Other Sexually Transmitted Infections Causing Urethritis Among High-risk Heterosexual Male Patients in Estonia." Infectious Diseases (London, England), vol. 50, no. 2, 2018, pp. 133-139.
Tjagur S, Mändar R, Punab M. Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia. Infect Dis (Lond). 2018;50(2):133-139.
Tjagur, S., Mändar, R., & Punab, M. (2018). Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia. Infectious Diseases (London, England), 50(2), pp. 133-139. doi:10.1080/23744235.2017.1366044.
Tjagur S, Mändar R, Punab M. Prevalence of Mycoplasma Genitalium and Other Sexually Transmitted Infections Causing Urethritis Among High-risk Heterosexual Male Patients in Estonia. Infect Dis (Lond). 2018;50(2):133-139. PubMed PMID: 28868962.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia. AU - Tjagur,Stanislav, AU - Mändar,Reet, AU - Punab,Margus, Y1 - 2017/09/04/ PY - 2017/9/5/pubmed PY - 2018/10/3/medline PY - 2017/9/5/entrez KW - Chlamydia trachomatis KW - Mycoplasma genitalium; Neisseria gonorrhoeae KW - inflammation KW - male KW - risk behaviour KW - sexually transmitted infections; Trichomonas vaginalis KW - urethritis SP - 133 EP - 139 JF - Infectious diseases (London, England) JO - Infect Dis (Lond) VL - 50 IS - 2 N2 - BACKGROUND: We aimed to evaluate the prevalence of sexually transmitted infections (STI, including Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) among high-risk heterosexual male patients and to clarify their potency to cause complaints and inflammation. METHODS: The study group included 825 men (18.0-49.5 y) consulting andrologist at Tartu University Hospital (Estonia) due to subjectively perceived risk of STI. Patients completed STI risk behaviour questionnaire. First voided urine was analysed for white blood cells and STIs. RESULTS: In total 193 (23.4%) patients were positive for one or multiple STI. The prevalence of C. trachomatis, M. genitalium, N. gonorrhoeae, T. vaginalis and combined STI was 14.3%, 4.4%, 2.7%, 0.7% and 1.3%, respectively. N. gonorrhoeae had the highest potency to generate inflammatory reaction in first voided urine (100%) followed by C. trachomatis (72.0%), M. genitalium (63.9%) and T. vaginalis (33.3%). N. gonorrhoeae and T. vaginalis caused the highest mean number of complaints while half of T. vaginalis cases and nearly fifth of M. genitalium and C. trachomatis cases were asymptomatic. CONCLUSIONS: C. trachomatis has the highest prevalence among Estonian high-risk men but M. genitalium holds an important second place. Prevalence of combined STIs is low. N. gonorrhoeae has the highest potency to generate urethral inflammation followed by C. trachomatis and M. genitalium. The highest number of complaints is also associated with N. gonorrhoeae while half of T. vaginalis cases and nearly a fifth of M. genitalium and C. trachomatis cases are asymptomatic. SN - 2374-4243 UR - https://www.unboundmedicine.com/medline/citation/28868962/Prevalence_of_Mycoplasma_genitalium_and_other_sexually_transmitted_infections_causing_urethritis_among_high_risk_heterosexual_male_patients_in_Estonia_ L2 - http://www.tandfonline.com/doi/abs/10.1080/23744235.2017.1366044 DB - PRIME DP - Unbound Medicine ER -